---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-036366"
form_type: "8-K"
ticker: "TRAW"
cik: "0001130598"
company_name: "Traws Pharma, Inc."
filed_at: "2025-04-18T23:59:59+00:00"
generated_at: "2026-05-23T10:55:29.030252+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Traws Pharma finalizes interim CEO Iain Dukes' employment; Jack Stover named Chairman

## Summary
- Employment agreement with Iain Dukes effective April 1, 2025: base salary $610K, target bonus 50% of base.
- Term of one year, auto-renew; severance only after first anniversary unless change in control.
- Dr. Dukes stepped down as Chairman on April 15, 2025; director Jack Stover appointed Chairman.
- Dr. Dukes remains a board member after transitioning chairman role.
- Agreement replaces April 2024 offer letter; details in Exhibit 10.1.

## SEC filing metadata
- accession: 0001104659-25-036366
- form_type: 8-K
- ticker: TRAW
- cik: 0001130598
- company_name: Traws Pharma, Inc.
- filed_at: 2025-04-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130598/000110465925036366/0001104659-25-036366-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130598/000110465925036366/tm2512673d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-036366
- JSON: https://secwatch.observer/filing/0001104659-25-036366.json
- Plain text: https://secwatch.observer/filing/0001104659-25-036366.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.